Groowe Groowe / Newsroom / AMGN
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AMGN News

Amgen Inc

More Than 30 Million Americans Living with Rare Diseases

prnewswire.com
AMGN SNY AGIO ASND DVA INCY NVS PFE REGN UCB

Chemotherapy Induced Peripheral Neuropathy (CIPN) Treatment Market Report 2026-2032: Revenues to Grow by $750M at 8.64% CAGR

globenewswire.com
ABBV AMGN PFE BMY MRK REGN SNY TAK NVS GSK HRTX

Omalizumab is as Effective as Multi-Food Oral Immunotherapy for Allergenic Food Tolerability

prnewswire.com
AMGN

Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D

businesswire.com
NVS BMY AMGN

Form 8-K

sec.gov
AMGN

Impact Podcast with John Shegerian Announces All-Star Roster for New Season

businesswire.com
CROX AMZN MSFT V ZM CBRE HPQ IBM UBER PEP AVD NU TD UPS CRM FTI AMGN HON KHC MAR MORN FDX HTHT LVS SCL SNA WMT XOM GE JNJ KO PG TGT DIS MCD SBUX BA CAT DD EMR LMT MMM NEE RTX UNH XRAY ZTS AMAT ADSK BIIB BMY CDNS CHKP CTAS CTSH DLTR EA EXPE FAST FIS GILD GOOG HAS HPE INTC INTU ISRG JD LRCX LIN LULU LYFT MDLZ MNST MRNA MU NFLX NVDA ORCL PAYX PDD PFE PLTR PPC QCOM REGN ROST SIRI SNPS SWKS SYK TCOM TEAM TER TFX TXN ULTA VRSK VRTX WDC WEC WST WYNN XEL ZBRA SAN

Cedar Health Research and Texas Native Health Expand Partnership with Embedded Clinical Research Site to Increase Patient Access to Trials

prnewswire.com
LLY AMGN SNY

Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research

prnewswire.com
TMO MRK BIO BIIB AMGN GILD REGN CRSP NTLA BMY ABBV AZN NVS PFE JNJ MRNA BNTX COR STEM ALGN EXAS MDLZ BHC CVS UNH CI CNC ELAN ZTS ISRG QRVO SWKS AVGO QCOM INTC MSFT GOOG AMZN IBM ORCL CRM ADBE NFLX DIS MCD SBUX KO PEP PG JPM BAC WFC C GS MS AXP V MA HD LOW COST TGT WMT BBY CMCSA VZ T XOM CVX SIRI UBER LYFT NVDA AMD MU AMAT LRCX ASML ADI TXN QGEN ILMN VRTX EDIT BEAM SRPT ACAD ALKS MDT SYK DHR GOOGL

U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs

globenewswire.com
BMY GILD JNJ SNY TAK AMGN AZN LLY MRK PFE REGN VRTX ABBV ALNY AMTX BIIB BMRN CRSP EXAS INCY IONS JAZZ NTLA PTC RGEN XOM

Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight

prnewswire.com
AMGN CNTB NKTR APGE LLY OGN ABBV PFE REGN INCY